Background: Although cognitive impairment is common and disabling in multiple sclerosis (MS), there are no approved pharmacological treatments for it. Fortunately, there is now good evidence that cognitive rehabilitation is effective in MS. However, most healthcare providers are unaware of these treatment options.
View Article and Find Full Text PDFBackground: Cognitive impairment is common in multiple sclerosis (MS) and can have an impact on all aspects of daily life. It is also an early marker of increased MS disease activity and indicates the need to optimise disease-modifying therapies to slow progression and preserve brain functioning. However, it is difficult to detect on clinical interview alone, and patient self-report is unreliable.
View Article and Find Full Text PDFEvidence supporting the direct therapeutic benefits of neuropsychological assessment (NPA) feedback relies mostly upon post-feedback consumer surveys. This randomized-controlled trial with cross-over investigated the benefits of NPA feedback in multiple sclerosis (MS). Seventy-one participants were randomly allocated to NPA with feedback or a "delayed-treatment" control group.
View Article and Find Full Text PDFSevere traumatic brain injury (sTBI) often results in significant morbidity, with fewer than 50% returning to work and only a minority resuming leisure and social activity. Yet few effective interventions are available for non-vocational activity. The aim of the study was to develop a new goal-directed intervention, the Programme for Engagement, Participation and Activities (PEPA), and evaluate its effect.
View Article and Find Full Text PDF